SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-16-460503
Filing Date
2016-02-12
Accepted
2016-02-11 20:18:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARMACEUTICALS INC d134996dsc13ga.htm SC 13G/A 36296
  Complete submission text file 0001193125-16-460503.txt   37789
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 161413777
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BUSH STREET SUITE 900 SAN FRANCISCO CA 94104
Business Address ONE BUSH STREET SUITE 900 SAN FRANCISCO CA 94104 4155912700
RS INVESTMENT MANAGEMENT CO LLC (Filed by) CIK: 0001085256 (see all company filings)

IRS No.: 943321067
Type: SC 13G/A